HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:HLN • US4055521003
10.84 USD
+0.35 (+3.34%)
Last: Feb 4, 2026, 11:15 AM
Overall HLN gets a fundamental rating of 5 out of 10. We evaluated HLN against 191 industry peers in the Pharmaceuticals industry. While HLN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLN has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year HLN was profitable.
- In the past year HLN had a positive cash flow from operations.
- In the past 5 years HLN has always been profitable.
- Each year in the past 5 years HLN had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 4.20%, HLN belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 8.92%, HLN belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
- HLN has a Return On Invested Capital of 6.11%. This is amongst the best in the industry. HLN outperforms 83.77% of its industry peers.
- HLN had an Average Return On Invested Capital over the past 3 years of 6.15%. This is significantly below the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
- HLN's Profit Margin of 12.84% is amongst the best of the industry. HLN outperforms 85.34% of its industry peers.
- HLN's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 21.31%, HLN belongs to the top of the industry, outperforming 89.53% of the companies in the same industry.
- In the last couple of years the Operating Margin of HLN has grown nicely.
- With a decent Gross Margin value of 60.75%, HLN is doing good in the industry, outperforming 70.68% of the companies in the same industry.
- In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
- The number of shares outstanding for HLN has been reduced compared to 1 year ago.
- The number of shares outstanding for HLN has been reduced compared to 5 years ago.
- The debt/assets ratio for HLN is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.34 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of HLN (2.34) is better than 63.35% of its industry peers.
- HLN has a debt to FCF ratio of 5.11. This is a neutral value as HLN would need 5.11 years to pay back of all of its debts.
- HLN's Debt to FCF ratio of 5.11 is amongst the best of the industry. HLN outperforms 83.77% of its industry peers.
- A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
- HLN has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: HLN underperforms 64.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.34 |
ROIC/WACC0.72
WACC8.51%
2.3 Liquidity
- HLN has a Current Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
- HLN's Current ratio of 0.98 is on the low side compared to the rest of the industry. HLN is outperformed by 85.34% of its industry peers.
- HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
- HLN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. HLN is outperformed by 83.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
- HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
- Measured over the past years, HLN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.56% on average per year.
- HLN shows a decrease in Revenue. In the last year, the revenue decreased by -0.61%.
- HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%0.68%
3.2 Future
- HLN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.56% yearly.
- The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y5.72%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
EPS Next 5Y9.56%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.25%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- HLN is valuated rather expensively with a Price/Earnings ratio of 21.68.
- 80.63% of the companies in the same industry are more expensive than HLN, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 28.18. HLN is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 18.49, which indicates a rather expensive current valuation of HLN.
- HLN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HLN is cheaper than 79.58% of the companies in the same industry.
- HLN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.68 | ||
| Fwd PE | 18.49 |
4.2 Price Multiples
- 82.72% of the companies in the same industry are more expensive than HLN, based on the Enterprise Value to EBITDA ratio.
- 86.39% of the companies in the same industry are more expensive than HLN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.79 | ||
| EV/EBITDA | 15.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.79
PEG (5Y)1.23
EPS Next 2Y7.77%
EPS Next 3Y8.45%
5. Dividend
5.1 Amount
- HLN has a Yearly Dividend Yield of 1.83%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.62, HLN pays a better dividend. On top of this HLN pays more dividend than 92.15% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.83, HLN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
5.2 History
- HLN has paid a dividend for at least 10 years, which is a reliable track record.
- HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- HLN pays out 39.53% of its income as dividend. This is a sustainable payout ratio.
DP39.53%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
NYSE:HLN (2/4/2026, 11:15:07 AM)
10.84
+0.35 (+3.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners58.32%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap48.27B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.78 (8.67%)
Short Float %0.45%
Short Ratio2.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
Yearly Dividend0.18
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.9%
PT rev (3m)3.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.68 | ||
| Fwd PE | 18.49 | ||
| P/S | 3.14 | ||
| P/FCF | 17.79 | ||
| P/OCF | 15.33 | ||
| P/B | 2.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.46 |
EPS(TTM)0.5
EY4.61%
EPS(NY)0.59
Fwd EY5.41%
FCF(TTM)0.61
FCFY5.62%
OCF(TTM)0.71
OCFY6.52%
SpS3.45
BVpS4.97
TBVpS-3.09
PEG (NY)3.79
PEG (5Y)1.23
Graham Number7.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.34 |
F-Score6
WACC8.51%
ROIC/WACC0.72
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.72%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
EPS Next 5Y9.56%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%0.68%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.25%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.32%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
Can you provide the valuation status for HALEON PLC-ADR?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for HLN stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 21.68 and the Price/Book (PB) ratio is 2.18.
Can you provide the dividend sustainability for HLN stock?
The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 39.53%.